Acceleron Pharma (XLRN) Names New Board Chair

April 6, 2015 7:09 AM UTC Send to a Friend
Acceleron Pharma (NASDAQ: XLRN) announced the appointment of Francois Nader, M.D., M.B.A, as the Chairman of its Board of Directors ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login